Harvest One Cannabis Inc (CVE:HVT)

Harvest One Cannabis Inc (CVE:HVT)

Share Price
$ 0.58
0.03 (5.45 %)
Market Cap
$124.17 m
Proactive Investors - Run By Investors For Investors

Harvest One Cannabis Inc

Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The Company's range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly-owned subsidiaries: United Greeneries,...

Market: TSX-V:HVT
52-week High/Low: C$1.150 / C$0.325
Sector: Cannabis
Market Cap: $124.17 m
Website: www.harvestone.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Harvest One Cannabis Inc

Harvest One Cannabis Inc Snapshot

Harvest One serves as the umbrella company over its four main subsidiaries: United Greeneries, Satipharm, Dream Water, and Delivra. Harvest One aims to add a portfolio of strategic investments within favourable jurisdictions to take advantage of the advancement of cannabis regulations globally. Harvest One's recent investment into Burb Cannabis represents the establishment of their Canadian cannabis retail vertical.


United Greeneries, Harvest One's cultivation arm, is a Canadian Licensed Producer under the Cannabis Act. United Greeneries has two main facilities, the Duncan Facility on Vancouver Island in BC and the Lucky Lake Facility in Saskatchewan.

United Greeneries is focused on developing premium products for both the recreation and medical markets and currently have provincial supply agreements with British Columbia, Saskatchewan, Manitoba and Ontario. Their Royal High and Captain’s Choice brands are available in retail stores in the four provinces. United Greeneries is one of a select number of LP’s that has a medicinal cannabis supply agreement with Shoppers Drug Mart under their medical cannabis brand, Satipharm. Patients can register and buy online from Shoppers Drug Mart in Ontario and Alberta. For more information please visit the United Greeneries website at www.unitedgreeneries.ca


Satipharm is a health & wellbeing company which is specialized in the development and manufacture of cannabinoid-based products from the cannabis plant. The Satipharm manufacturing process is in line with the international standards of Good Manufacturing Practice (GMP). This ensures that Satipharm only provides products of exceptional, consistent quality, that are manufactured in a regulated, safe environment.

Satipharm believes commercialization of its signature Gelpell® technology for cannabinoid products will transform the company into a global leader in the medical and health-based cannabis industry. In 2019, Satipharm’s marketing campaign is focused on near-term growth and is distributed throughout the EU and Australia. The company is concurrently preparing to import its products into Canada. Satipharm is dedicated to growing its portfolio of delivery technology IP with further expansion plans targeting introduction of other formulations including THC.

For more about Satipharm and its CBD Gelpell® technology, visit www.satipharm.com


Dream Water is the #1 selling natural, 2.5 oz, 0-calorie, liquid sleep shot. Along with its sleep powder, Dream Water helps promote relaxation and restful sleep. Dream Water has helped millions of individuals get a good night’s sleep without resorting to over-the-counter and prescription sleep-aids.

Fully approved by Health Canada, Dream Water contains melatonin, GABA and 5-HTP, three key ingredients that help people fall asleep, stay asleep and wake up feeling refreshed. The company currently has two distinct product lines: relaxation and beauty. Each of the lines is carefully designed to offer a different experience for the consumer based on their lifestyle.

Harvest One’s acquisition of Dream Water positions them as first movers both in the global cannabis and sleep markets, two robust industries that are expanding rapidly.


Delivra Corp. is a specialty biotechnology company having a proprietary transdermal delivery system platform that can shuttle pharmaceutical and natural molecules through the skin, in a targeted manner. Delivra manufactures and sells a growing line of natural topical creams with the proprietary transdermal delivery system platform under the LivReliefTM brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. LivReliefTM products are available in over 6,000 retail locations, including pharmacies, grocery chains, and independent health food stores across Canada, including, but not limited to, Shoppers Drug Mart, Walmart, Loblaw, Rexall, Pharmasave, London Drugs, and on-line at www.livrelief.com. In parallel with its consumer products business, Delivra also has a mandate to license its patent-pending, proprietary transdermal delivery technology platform to pharmaceutical companies globally, for the repurposing of pharmaceutical molecules transdermally to treat a broad range of conditions, along with licensing its over-the-counter products globally.

Grant Froese

Mr. Froese is a retail industry veteran with 38 years of experience at Loblaw, Canada’s largest food retailer, with his most recent position being Chief Operating Officer prior to his short-lived retirement in April 2017. Since August 2017, Froese served as the Chief Executive Officer for Marquee Health Group, a late stage applicant under the Access to Cannabis for Medical Purposes Regulation (ACMPR) where he gained valuable industry experience and insight. Mr. Froese has extensive experience in supply chain management, digital/ecommerce businesses, marketing, brand management and operations management.

Andrew Kain

Andrew Kain is a lawyer by profession with almost 25 years of extensive corporate, financial and legal experience. For 15 years, he was General Counsel to a US$5+ billion global hedge fund that operated a proprietary quantitative trading platform and managed a US$2+ billion fund of funds portfolio, where he worked with investment banks, brokerage houses, exchanges and regulatory bodies in capital markets around the globe. Most recently Andrew was in private practice providing general corporate, financial and advisory services to start-up and early stage companies in emerging industries. Andrew is also a founder and President of Windular Research and Technologies Inc., a privately held corporation that provides innovative renewable energy systems, consulting and advisory services to the global telecommunications industry.

Chris Podolsky
Interim CFO

Chris Podolsky is a Chartered Professional Accountant (CA) and has over 30 years of senior finance leadership experience with both public and private companies. Chris has been Corporate Controller for several multinational public companies, including Bird Construction, Parkland Fuel Corp and WorleyParsons Canada. He was CFO of Focus Corporation, a privately-held company, where he was instrumental in the growth and eventual sale of the company to WSP Global, and Gemini Corporation, a TSX-V listed company. Chris now provides strategy, financial and advisory guidance to several small businesses with an emphasis on shareholder value creation. He also has extensive experience with leading companies through acquisitions and business integration. Prior to his time in industry, Chris spent ten years working in public practice with KPMG in both Winnipeg and Turks and Caicos Islands. Chris earned the Chartered Accountant designation in 1994 and holds a Bachelor of Commerce degree from the University of Manitoba.

Nick Maltchev

Mr. Maltchev is a global executive with a passion for results and building great teams. He brings a mix of strategic thinking and deep technical knowledge and over 25 years of technology experience. He has been involved with the industry since 2004 and was an integral part of the Advanced Nutrients management team over a period of 12 years, holding several positions including information technology manager, COO and general manager. Mr. Maltchev holds a BBA degree, as well as other designations in project management, cybersecurity and computer science. He is also currently in the process of finishing an MBA in management information systems.

Will Stewart
SVP Corporate and Public Affairs

Mr. Stewart, a well-known Canadian cannabis executive, insider and former Harvest One Board member, is a leading influencer in cannabis and worked for years in political and corporate circles pushing for legalization and reducing stigma. He was named a Top 100 Lobbyist in Canada for seven consecutive years and received the Queen’s Diamond Jubilee Medal for contributions to Canadian public policy. In addition, Mr. Stewart has consulted to more than a dozen cannabis companies and was most recently Vice President at another vertically integrated cannabis company.

Jonathan Hartshorn
President of Satipharm

Jonathan holds a degree in Pharmacology and Physiology and is a Fellow of the Institute of Chartered Accountants. He has over 15 years experience in the Life Sciences arena, including Discovery, Development, Clinical Trials and OTC/ Grocery retail experience, as well as transaction experience including M&A and financings. He has held key leadership positions in Pfizer Consumer Healthcare Ireland, McNeil Healthcare and Venn Life Sciences Plc.


Frank Holler

Mr. Holler is President and CEO of Ponderosa Capital Inc.  An expert in biotechnology, investment banking and venture capital, Mr. Holler previously served as CEO and Partner of Lions Capital Corp., fund manager for BC Advantage Funds and the Lions Funds; as President and CEO of Xenon Pharmaceuticals Inc., a private genomics-based drug development company; as President and CEO of ID Biomedical Corporation, a vaccine development company sold to GlaxoSmithKline plc; and as a founding director of Angiotech Pharmaceuticals, a TSX/ NASDAQ listed medical device company. Before working in biotechnology and healthcare, Mr. Holler was an Investment Banker with Merrill Lynch Canada and Wood Gundy Inc. (now CIBC World Markets). Mr. Holler’s experience, particularly in the pharmaceutical industry and capital markets, strengthens the depth of expertise on the Harvest One Board.

Peter Wall

Peter Wall is a corporate lawyer based in Perth, Western Australia and is a Partner at one of Australia’s leading corporate and commercial law firms. He was a founding director and shareholder in Phytotech Medical Limited, the first medical cannabis company to list on the Australian Securities Exchange, which subsequently was renamed “MMJ Phytotech Ltd” after a merger with MMJ Biosciences Inc.

Jason Bednar

Jason Bednar is a Chartered Accountant with more than 18 years of direct professional experience in the financial and regulatory management of companies listed on the TSX, TSX-V, American Stock Exchange and ASX.

David Hyde

Mr. Hyde is Chief Operating Officer at Total Cannabis Security Solutions Inc., One of the country’s top security and compliance consultants, Mr. Hyde founded David Hyde & Associates Inc. which consulted on 65 Licensed Producer sites and more than 300 Licensed Producer applications to help LPs navigate security and compliance in the highly regulated legal cannabis industry. Mr. Hyde is the only Canadian member of the Security Committee for the Foundation of Cannabis Unified Standards.

Investor Relations
Colin Clancy
Email: [email protected]
Tel: 1-877-915-7934

Corporate Office
Suite 504
999 Canada Place
Vancouver, BC
V6C 3E1

Email: [email protected]

Tel: +1 604-449-9280

For Corporate Information, please click here

Video RSS



© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use